Common use of Exchange Act Registration and Listing of the Common Stock Clause in Contracts

Exchange Act Registration and Listing of the Common Stock. The Company’s Common Stock is registered pursuant to Section 12(b) of the Exchange Act and listed on the Principal Trading Market; the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Principal Trading Market, nor has the Company received any notification that the Commission or FINRA is contemplating terminating such registration or listing. Except as disclosed on Schedule 4(bb), the Company has not, since the effective date of its initial public offering, received notice from any Trading Market on which the shares of Common Stock are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirement of such Trading Market. Except as disclosed on Schedule 4(bb), the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Shares are currently eligible for electronic transfer through the DTC or another established clearing corporation and the Company is current in payment of the fees to the DTC (or such other established clearing corporation) in connection with such electronic transfer.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Sonendo, Inc.), Securities Purchase Agreement (Sonendo, Inc.)

AutoNDA by SimpleDocs

Exchange Act Registration and Listing of the Common Stock. The Company’s Common Stock is registered pursuant to Section 12(b) of the Exchange Act and listed on the Principal Trading Market; the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Principal Trading Market, nor has the Company received any notification that the Commission or FINRA is contemplating terminating such registration or listing. Except as disclosed on Schedule 4(bb), the The Company has not, since in the effective 12 months preceding the date of its initial public offeringhereof, received notice from any Trading Market on which the shares of Common Stock are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirement of such Trading Market. Except as disclosed on Schedule 4(bb), the The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Shares are currently eligible for electronic transfer through the DTC Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the DTC Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

Appears in 1 contract

Samples: Securities Purchase Agreement (Heron Therapeutics, Inc. /De/)

AutoNDA by SimpleDocs

Exchange Act Registration and Listing of the Common Stock. The Company’s Common Stock is registered pursuant to Section 12(b) of the Exchange Act and listed on the Principal Trading Market; the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Principal Trading Market, nor has the Company received any notification that the Commission or FINRA is contemplating terminating such registration or listing. Except as disclosed on Schedule 4(bb3.1(y), the Company has not, since in the effective 12 months preceding the date of its initial public offeringhereof, received notice from any Trading Market on which the shares of Common Stock are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirement of such Trading Market. Except as disclosed on Schedule 4(bb), the The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Shares are currently eligible for electronic transfer through the DTC Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the DTC Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

Appears in 1 contract

Samples: Securities Purchase Agreement (Heron Therapeutics, Inc. /De/)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!